CIK 0001840229 · <br>Emerging growth company
MiNK Therapeutics, Inc.
Sign in to watch- Ticker
- INKT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 212-994-8250
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 1,612 shares (grant or award)
- 4 Grant or award Director acquired 1,466 shares (grant or award)
- 4 Grant or award Director acquired 1,601 shares (grant or award)
- 4 Grant or award Director acquired 1,128 shares (grant or award)
- 4 Grant or award Director acquired 1,218 shares (grant or award)
- 4 Grant or award Director acquired 1,263 shares (grant or award)
- 4/A Shares withheld for taxes Chief Executive Officer gave up 5,351 shares (to pay taxes)
- 4 Grant or award Chief Executive Officer acquired 18,229 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 1,011 shares (grant or award)
- 4 Grant or award Director acquired 975 shares (grant or award)
- 4 Grant or award Director acquired 1,281 shares (grant or award)
- 4 Insider Changes in Ownership
Page 2 of 8 · 145 filings